Back to all news

KitoZyme expands its digestive range and presents medical results at CPHI Frankfurt.

 

KitoZyme is already well-known for its expertise in the Weight Management. However, 2016 was the year of innovation with the launch of a new product range in Digestive Health.

Having experimented successfully with these products, KitoZyme has launched TransiBiota®, which is a new medical device for:

  • The treatment of moderate constipation,
  • The promotion of normal transit
  • The relief of gastro-intestinal symptoms related to constipation and/or gut dysbiosis.

TransiBiota® is available in a convenient delivery form: 1 to 2 sachet(s)/day with an orange flavor.

 

KitoZyme also presents the results of its user test of FiberSlim™ with 22 patients under medical control.

FiberSlim™ is a medical device that reduces caloric intake, restores a healthy gut microflora and reduces oxidative stress.

We were able to demonstrate:

  • A quick effect on digestive symptoms
  • A feeling of digestive well-being thanks to improved transit and a feeling of “deflation”.
  • A rapid and progressive weight loss from the beginning: 2.3 kg in just 4 weeks.

All of these products are composed of our unique, 100% natural and patented ingredientKiOtransine® and other ingredients in order to create the best combinations. These four products constitute the new range in Digestive Health and permit KitoZyme to further strengthen its area of expertise.

 

Visit us at Booth 91F49 at CPHI Frankfurt

To receive more information on these products or our other products in Weight Management, feel free to contact us or visit us at Booth 91F49 Hall 9.1 at CPHI Frankfurt.